logo

Alembic Pharmaceuticals Ltd. Financials

10:39 Jun 19

Alembic Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
950.30
-8.50 (-0.89%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Alembic Pharmaceuticals Ltd. Financials

Alembic Pharmaceuticals Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
950.30
-8.50 (-0.89%)
10:39 Jun 19
Quality
image/svg+xml

55/100
High Financial Strength

Valuation
image/svg+xml

32/100
Mid Valuation

Technical

46/100
Technically Neutral

Strength

6

Weakness

3

Opportunity

1

Threats

0

11.23 %

ROE %

7.50 %

ROA %

29.68

EPS

264.10

BVPS

8.74 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
5393.13 5305.79 5652.62 6228.62 6672.08
Operating Expenses +
3835.58 4431.63 4944.24 5295.27 5663.84
Raw Material
1451.27 1489.61 1630.17 1857.92 2083.13
Increase Decrease in Cost
-193.93 -43.19 78.65 -142.84 -289.77
Other Manufacturing Expense
22.39 0 50.9 0 0
Employee Cost
1051.17 1133 1169.13 1446.29 1562.34
Miscellaneous Expenses
2036.52 2573.21 2775.57 3043.72 3130.06
Operating Profit
1557.55 874.16 708.38 933.35 1008.24
Other Income
10.02 50.46 2.74 28.31 42.55
Depreciation
183.47 286.78 275.43 272.67 278.58
Interest
16.02 17.73 50.17 56.19 78.77
Profit before tax and exceptio..
1368.08 620.11 385.52 632.8 693.44
Exceptional Items
0 0 0 0 12.87
PBT
1368.08 620.11 385.52 632.8 706.31
Provision for Taxation
253.32 104.46 12.61 16 125.17
Net Profit
1114.76 515.65 372.91 616.8 581.14
NET Profit after MI
1178.11 520.94 341.99 615.82 583.42
EPS
60.81 26.5 17.4 31.33 29.68
Operating Profit Margin (%)
28.88 16.48 12.53 14.98 15.11
Net Profit Margin (%)
21.84 9.82 6.05 9.89 8.74

Alembic Pharmaceuticals Ltd. Shareholding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 69.70 69.60 69.60 69.60 69.60
FII 3.90 4.20 3.90 4.30 4.50
MF 9.20 9.00 8.90 8.00 7.80
Others 7.20 7.00 7.20 7.50 7.50
Shareholder Shares Holding %
Research 360 logo
Download Our App On: